Quarterly Result5 Nov 2026, 07:12 pm
Fredun Pharma Declares Un-Audited Q2 FY27 Results
AI Summary
Fredun Pharmaceuticals Ltd announced its un-audited financial results for the Quarter and Half-Year Ended September 30, 2026. The company's board also approved an application for listing its equity shares on the National Stock Exchange (NSE). The trading window for company insiders closed on October 1, 2026, and will reopen 48 hours after the declaration of the board meeting outcome. The board meeting commenced at 10:00 a.m. and concluded at 11:10 a.m.
Key Highlights
- Board approved un-audited financial results for Q2 FY27.
- Company to apply for NSE listing.
- Trading window for insiders remains closed.
- Limited review report issued by statutory auditors.
Price Impact
More from FREDUN